These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 7921520
1. Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density? Dören M, Schneider HP. Int J Clin Pharmacol Ther; 1994 May; 32(5):254-8. PubMed ID: 7921520 [Abstract] [Full Text] [Related]
2. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN. Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449 [Abstract] [Full Text] [Related]
3. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. Marslew U, Overgaard K, Riis BJ, Christiansen C. Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944 [Abstract] [Full Text] [Related]
5. Rapid increase in lumbar spine bone density in osteopenic women by high-dose intramuscular estrogen-progestogen injections. A preliminary report. Ulrich U, Pfeifer T, Lauritzen C. Horm Metab Res; 1994 Sep; 26(9):428-31. PubMed ID: 7835827 [Abstract] [Full Text] [Related]
7. [Postmenopausal osteoporosis from the viewpoint of the gynecologist]. Dören M, Schneider HP. Z Gesamte Inn Med; 1992 Dec; 47(12):568-72. PubMed ID: 1285464 [Abstract] [Full Text] [Related]
9. [Treatment of osteoporosis by the gynecologist]. Schneider HP, Dören M. Zentralbl Gynakol; 1994 Dec; 116(12):691-4. PubMed ID: 7846982 [Abstract] [Full Text] [Related]
10. A 10-year follow-up of the effect of continuous-combined hormone replacement therapy and its discontinuation on bone in postmenopausal women. Heikkinen J, Vaheri R, Haapalahti J, Timonen U. Menopause Int; 2008 Jun; 14(2):70-7. PubMed ID: 18519268 [Abstract] [Full Text] [Related]
12. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis. Warming L, Ravn P, Christiansen C. Maturitas; 2005 Feb 14; 50(2):78-85. PubMed ID: 15653003 [Abstract] [Full Text] [Related]
15. Use of low-dosage 17 beta-estradiol for the prevention of osteoporosis. Ettinger B. Clin Ther; 1993 Feb 14; 15(6):950-62; discussion 949. PubMed ID: 8111815 [Abstract] [Full Text] [Related]
17. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes]. Brodowska A. Ann Acad Med Stetin; 2003 Feb 14; 49():111-30. PubMed ID: 15552843 [Abstract] [Full Text] [Related]
19. Hormone replacement therapy increases trabecular and cortical bone density in osteoporotic women. Bagur A, Wittich A, Ghiringhelli G, Vega E, Mautalen C. Medicina (B Aires); 1996 Feb 14; 56(3):247-51. PubMed ID: 9035480 [Abstract] [Full Text] [Related]
20. Quantitative assessment of bone mineral density during estrogen replacement therapy. Thijssen JH, Druckmann R. Gynecol Endocrinol; 1999 Dec 14; 13 Suppl 6():29-34. PubMed ID: 10862266 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]